UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): September 17, 2013

 

 

ZOSANO, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   333-179130   46-0525801

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

34790 Ardentech Court

Fremont, CA 94555

(Address of principal executive offices) (Zip Code)

(510) 745-1200

Registrant’s telephone number, including area code

Eco Planet Corp.

93 S. Jackson Street, #34786

Seattle, WA 98104-2818

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 1.01 Entry into a Material Definitive Agreement.

Reference is made to the disclosure set forth under Item 5.01 of this Current Report on Form 8-K, which disclosure is incorporated herein by reference.

 

Item 3.02 Unregistered Sales of Equity Securities.

Reference is made to the disclosure set forth under Item 5.01 of this Current Report on Form 8-K, which disclosure is incorporated herein by reference.

 

Item 5.01 Changes in Control of Registrant.

On October 31, 2013, Zosano, Inc. (the “Company,” “we” or “us”) entered into a Stock Purchase Agreement (the “Purchase Agreement”) with ZP Holdings, Inc., a Delaware corporation (“ZP Holdings”), pursuant to which we issued and sold to ZP Holdings, on October 31, 2013, 10,016,973 shares (the “Shares”) of our of common stock, $0.0001 par value per share (the “Common Stock”), for an aggregate cash purchase price of $365,000. We sometimes refer to the issuance and sale of the Shares to ZP Holdings pursuant to the Purchase Agreement as the “Change in Control Transaction.”

Neither the Company nor its affiliates has any material relationship with ZP Holdings, other than in respect of the Purchase Agreement and the transactions thereunder. There were no underwriters, and there were no underwriting discounts or commissions, in respect of the Purchase Agreement or the transactions thereunder.

The issuance and sale of the Shares to ZP Holdings pursuant to the Purchase Agreement was deemed to be exempt from registration under the Securities Act of 1933 (the “Securities Act”), in reliance upon Section 4(a)(2) of the Securities Act (or Regulation D promulgated thereunder) as a transaction by an issuer not involving any public offering. ZP Holdings represented and warranted in the Purchase Agreement that it is an accredited investor as defined in Rule 501(a) of Regulation D, and we reasonably believed immediately prior to the closing of the Change in Control Transaction that ZP Holdings was an accredited investor.

As a result of the issuance and sale of the Shares to ZP Holdings pursuant to the Purchase Agreement, a change in control of the Company occurred (in which ZP Holdings acquired control of the Company). As of immediately following the Change in Control Transaction, 10,027,000 shares of our Common Stock were issued and outstanding. The 10,016,973 shares of Common Stock issued and sold to ZP Holdings pursuant to the Purchase Agreement represent approximately 99.9% of our issued and outstanding Common Stock after giving effect to the issuance and sale of the Shares to ZP Holdings. ZP Holdings used its available cash to fund its purchase of the Shares, and assumed control of the Company from Elka Yaron, one of the Company’s founders, who prior to the Change in Control Transaction held approximately 60% of our issued and outstanding Common Stock.

Other than pursuant to the Purchase Agreement, which required, as a condition of ZP Holdings’ obligation thereunder to purchase the Shares from the Company, that the individuals designated by ZP Holdings be elected to the Board of Directors and as officers of the Company in each case effective upon the closing of the Change in Control Transaction, and that the directors

 

2


and officers of the Company immediately prior to the closing of the Change in Control Transaction resign from their positions with the Company effective upon the closing, there are no arrangements or understandings among members of both the former and new control groups and their associates with respect to the election of directors or other matters. In addition, we are unaware of any arrangement the operation of which may at a subsequent date result in a change in control of the Company.

Immediately before the Change in Control Transaction, the Company was a shell company as defined in Rule 12b-2 promulgated under the Securities Exchange Act of 1934 (the “Exchange Act”). Item 5.01(a)(8) of Form 8-K requires that, under those circumstances, a registrant must disclose the information that would be required if the registrant were filing a general form for registration of securities on Form 10 under the Exchange Act. Accordingly, we are providing such information for the Company below.

The information required by Items 1, 1A and 6 of Form 10 is incorporated herein by reference to Items 1, 1A and 11, respectively, of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012 filed on February 26, 2013. The information required by Items 2 and 8 of Form 10 is incorporated herein by reference to Item 2 of Part I and Item 1 of Part II, respectively, of the Company’s Quarterly Report on Form 10-Q/A for the quarterly period ended June 30, 2013 filed on August 2, 2013. The information required by Item 10 of Form 10 is incorporated herein by reference to the information under the heading “Recent Sales of Unregistered Securities; Use of Proceeds from Sale of Registered Securities” under Item 5 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012 filed on February 26, 2013 and to the section of Part II of the Company’s Registration Statement on Form S-1/A filed on May 2, 2012 titled “Recent Sales of Unregistered Securities,” as supplemented by the information regarding the Company’s issuance and sale of the Shares to ZP Holdings pursuant the Purchase Agreement provided above in this Current Report on Form 8-K. The information required by Item 11 of Form 10 is not applicable for the purposes of this Current Report on Form 8-K.

The information required by Item 13 of Form 10 is incorporated herein by reference to Item 8 of Part II of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012 filed on February 26, 2013, the financial statements and notes thereto included in the Company’s Quarterly Report on Form 10-Q/A for the fiscal quarter ended March 31, 2013 filed on August 2, 2013 and the financial statements and notes thereto included in the Company’s Quarterly Report on Form 10-Q/A for the fiscal quarter ended June 30, 2013 filed on August 2, 2013. The list of financial statements required by Item 15 of Form 10 is incorporated herein by reference to page F-1 of Item 8 of Part II of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012 filed on February 26, 2013, page F-1 of the Company’s Quarterly Report on Form 10-Q/A for the fiscal quarter ended March 31, 2013 filed on August 2, 2013 and page F-1 of the Company’s Quarterly Report on Form 10-Q/A for the fiscal quarter ended June 30, 2013 filed on August 2, 2013. The exhibits required by Item 15 of Form 10 are included in Item 9.01 of this Current Report on Form 8-K and are incorporated herein by reference.

In response to Item 3 of Form 10, our corporate headquarters are located at 34790 Ardentech Court, Fremont, California 94555. There is no charge to the Company for the space. We do not own any real property.

 

3


In response to Item 4 of Form 10, the following table sets forth certain information regarding the beneficial ownership of our Common Stock by (i) each person who, to our knowledge, owns more than 5% of our Common Stock, (ii) each of our directors and named executive officers, and (iii) all of our current executive officers and directors as a group. The information set forth in the table below is based on 10,027,000 shares of our Common Stock issued and outstanding on October 31, 2013, giving effect to the Change in Control Transaction.

 

Name of Beneficial Owner (1)

   Outstanding      Right to
Acquire
     Total      Percentage  

5%+ Stockholders

           

ZP Holdings, Inc.

34790 Ardentech Court

Fremont, CA 94555

     10,016,973         —           10,016,973         99.90

Directors and Named Executive Officers

           

Vikram Lamba

     —           —           —           —     

Peter Daddona

     —           —           —           —     

John Richard

     —           —           —           —     

M. James Barrett

     —           —           —           —     

Kleanthis Xanthopoulos

     —           —           —           —     

Bruce Steel

     —           —           —           —     

Christopher Krueger

     —           —           —           —     

Current Directors and Executive Officers as a Group (7 persons)

     —           —           —           —     

 

(1) Except as otherwise indicated, we believe that the beneficial owners of the Common Stock, based on information furnished by such owners, have sole investment and voting power with respect to such shares, subject to community property laws where applicable. Beneficial ownership is determined in accordance with the rules of the Securities and Exchange Commission and generally includes voting or investment power with respect to securities.

The following information regarding our directors and executive officers is provided in response to Item 5 of Form 10. At the time immediately prior to the Change in Control Transaction, the number of members of our Board of Directors was fixed at two. Effective upon, and as a condition of, the closing of the transactions under the Purchase Agreement, Elka Yaron and Aharon Shnitzer resigned as members of our Board of Directors and the individuals identified in the table below were appointed to our Board of Directors. In addition, effective upon, and as a condition of, the closing of the transactions under the Purchase Agreement, Elka Yaron and Aharon Shnitzer resigned as officers of the Company and the individuals identified in the table below were appointed as officers of the Company. The following individuals serve as our current directors and executive officers:

 

4


Name

  

Position

   Age
Bruce Steel    Director    47
M. James Barrett    Director    70
John Richard    Director    56
Kleanthis Xanthopoulos    Director    55
Peter Daddona    Director    68
Vikram Lamba    Chief Executive Officer, President, Treasurer and Director    47
Christopher Krueger    Chief Business Officer and Secretary    45

On September 17, 2013, our Board of Directors and the requisite number of our stockholders, acting by written consent in lieu of a meeting, approved an amendment to our certificate of incorporation creating a classified board of directors. Effective October 21, 2013, our Board of Directors was divided into three classes designated as Class I, Class II and Class III, respectively, with each class serving staggered three-year terms. Directors were assigned to each class in accordance with a resolution adopted by the Board of Directors. At the 2014 annual meeting of stockholders, which will be the Company’s first annual meeting of stockholders following the initial classification of the Board of Directors, the term of office of the Class I directors will expire and Class I directors will be elected for a full term of three years. At the second annual meeting of stockholders following the initial classification, the term of office of the Class II directors will expire and Class II directors will be elected for a full term of three years. At the third annual meeting of stockholders following the initial classification, the term of office of the Class III directors will expire and Class III directors will be elected for a full term of three years. At each succeeding annual meeting of stockholders, directors will be elected for a full term of three years to succeed the directors of the class whose term expires at such annual meeting. In any event, each director serves until his or her successor has been duly elected and qualified, or until the director’s earlier death, resignation or removal. The text of the classified board amendment can be found in Article V, Section A.2 of our Amended and Restated Certificate of Incorporation, as amended, attached as Exhibits 3.1, 3.2, 3.3 and 3.4 to this Current Report on Form 8-K.

To our knowledge, no family relationships exist between any of our current directors or executive officers. To our knowledge, no director, executive officer, significant employee or control person of the Company has been involved in any legal proceeding listed in Item 401(f) of Regulation S-K in the past ten years. The information regarding our directors and executive officers provided in response to Item 7 of Form 10 in this Current Report on Form 8-K is incorporated herein by reference. The following is a brief description of the education and business experience of our current directors and executive officers:

 

5


Bruce Steel

Mr. Steel has served as a member of our Board of Directors since the closing of the transactions under the Purchase Agreement on October 31, 2013. He is currently the Managing Director of BioMed Ventures, the strategic investment arm of BioMed Realty Trust, and serves as a member of the Board of Directors of ZP Holdings. Previously, Mr. Steel served as the Chief Executive Officer of Rincon Pharmaceuticals, Inc. and, between 2008 and 2010, as the Chief Business Officer of Anaphore, Inc. Mr. Steel received his Bachelor of Arts from Dartmouth College and his M.B.A. from the Marshall School of Business at the University of Southern California. He also holds the designation of Chartered Financial Analyst. We believe that Mr. Steel’s executive and board level experience at various companies qualify him to serve as a member of our Board of Directors.

M. James Barrett

Mr. Barrett has served as a member of our Board of Directors since the closing of the transactions under the Purchase Agreement on October 31, 2013. Mr. Barrett is a General Partner with New Enterprise Associates, Inc., where has served in that role since 2001. In addition to our Board of Directors, Mr. Barrett currently serves as a member of the Board of Directors of ZP Holdings, Amicus Therapeutics, Inc., Blend Biosciences, Inc., Cardioxyl Pharmaceuticals, Inc., Clovis Oncology, Inc., Galera Therapeutics, Inc., GlycoMimetics, Inc., PhaseBio Pharmaceuticals, Inc., Psaydon Pharmaceuticals, Roka Bioscience, Inc., Sensors for Medicine and Science, Inc., Supernus Pharmaceuticals, Inc. He formerly served on various other boards of directors, including at Targacept, Inc., CoGenesys, Inc., Iomai Corporation, MedImmune, LLC, PHarmion Corporation, and Inhibitex, Inc. Mr. Barrett received a Ph.D. in Biochemistry at the University of Tennessee, his M.B.A. from the University of Santa Clara, and a B.S. in Chemistry from Boston College. We believe that Mr. Barrett’s extensive experience serving on boards of directors of both public and private companies and his deep business experience qualify him to serve as a member of our Board of Directors.

John Richard

Mr. Richard has served as a member of our Board of Directors since the closing of the transactions under the Purchase Agreement on October 31, 2013. Mr. Richard is a consultant who provides advice on various transactions as well as interim management to biotechnology companies, and is a member of the Board of Directors of ZP Holdings. He is currently a Partner of Georgia Venture Partners in Atlanta, Georgia, a position he has held since 2005, and an Operating Partner at Phase4 Partners in London, a position he has held since 2008. He is a Manager of two affiliates of Georgia Venture Partners and became a Director of Phase4 Partners Ltd. in 2011. Mr. Richard received his M.B.A. from Harvard Business School and his B.S. from Stanford University. We believe that Mr. Richard’s extensive business development experience qualifies him to serve as a member of our Board of Directors.

Kleanthis Xanthopoulos

Dr. Xanthopoulos has served as a member of our Board of Directors since the closing of the transactions under the Purchase Agreement on October 31, 2013. Dr. Xanthopoulos is the President and Chief Executive Officer of Regulus Therapeutics Inc., having joined Regulus around its formation in 2007. He is also currently a member of the Board of Directors of ZP Holdings, Biotechnology Industry Organization (BIO), Sente Inc., Apricus Bioscience, Inc. and a

 

6


member of the executive board of BIOCOM, and was a member of the Board of Directors of Anadys Pharmaceuticals until 2011. Prior to joining Regulus, he was a managing director of Enterprise Partners Venture Capital. An Onassis Foundation scholar, Dr. Xanthopoulos received his B.Sc. in Biology with honors from Aristotle University of Thessaloniki, Greece, and received both his M.Sc. in Microbiology and Ph.D. in Molecular Biology from the University of Stockholm, Sweden. We believe that Dr. Xanthopoulos’ senior executive experience managing and developing a publicly traded company qualifies him to serve as a member of our Board of Directors.

Peter Daddona

Dr. Daddona has served as a member of our Board of Directors since the closing of the transactions under the Purchase Agreement on October 31, 2013. Dr. Daddona has been a director of ZP Holdings since its inception in January 2012, and has been Chief Scientific Officer of Zosano Pharma, Inc. since July 31, 2006. Dr. Daddona founded Zosano Pharma, Inc. in 2006 as a spin-off of Johnson & Johnson. Dr. Daddona earned his Ph.D. from the University of Connecticut and completed post-doctoral training at Duke University. We believe that Dr. Daddona’s experience as a director of ZP Holdings qualifies him to serve as a member of our Board of Directors.

Vikram Lamba

Mr. Lamba has served as our President and Chief Executive Officer and as a director since the closing of the transactions under the Purchase Agreement on October 31, 2013. Mr. Lamba has also served in such capacities at ZP Holdings since its inception in January 2012. Mr. Lamba served as Chief Financial Officer of Zosano Pharma, Inc. until April 2012 when the business was recapitalized and became a wholly owned subsidiary of ZP Holdings. Before that, Mr. Lamba served as Chief Financial Officer and Chief Business Officer of Predictive Biosciences, Inc. from July 2008 until he joined Zosano Pharma, Inc. in 2011. Prior to that, he served as Vice President of Corporate Development at Advanced Medical Optics, Inc. Mr. Lamba served as Vice President for Finance and Chief Financial Officer of GeneOhm Sciences, Inc. and has over 16 years of global experience in various positions with Burmah Castrol PLC and Bayer AG. He served for Castrol in Sales & Marketing and Business Development in India and Singapore for eight years. Mr. Lamba has an undergraduate degree in Mechanical Engineering and received an M.B.A. from the Asian Institute of Management and was an exchange student at The Wharton School of the University of Pennsylvania. We believe that Mr. Lamba’s extensive knowledge and his experience in corporate management qualify him to serve as a member of our Board of Directors.

Christopher Krueger

Mr. Krueger has served as our Chief Business Officer since the closing of the transactions under the Purchase Agreement on October 31, 2013. Mr. Krueger has also served in such capacity at ZP Holdings and Zosano Pharma, Inc. since February 2013. Prior to joining Zosano Pharma, Inc., Mr. Krueger served as an independent consultant, providing operational guidance to small biotech companies in corporate strategy, financing and partnership opportunities. From 2007 to 2010, he served as Senior Vice President and Chief Business Officer at Ardea Biosciences, Inc., a biopharmaceutical company focused on novel treatments for gout, cancer and HIV. Earlier in his career, Mr. Krueger was a corporate lawyer at Cooley LLP. Mr. Kruger holds a J.D. and M.B.A. from the University of Southern California and a B.A. in Economics from the University of California at San Diego.

 

7


The information required by Item 7 of Form 10 is incorporated herein by reference to Item 13 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012 filed on February 26, 2013, as supplemented and updated by the following information. The individuals who were appointed as our directors and executive officers effective upon the closing of the transactions under the Purchase Agreement – Bruce Steel, M. James Barrett, John Richard, Kleanthis Xanthopoulos, Peter Daddona, Vikram Lamba and Christopher Krueger – may be deemed to have indirect material interests in the Company’s sale and issuance of the Shares to ZP Holdings pursuant to the Purchase Agreement, as a result of their ownership of shares (or options to acquire shares) of common stock of ZP Holdings or their affiliations with stockholders of ZP Holdings:

 

    Bruce Steel is a limited partner with a variable economic interest in each of two limited partnerships that own outstanding common stock of ZP Holdings, which entitles Mr. Steel to a percentage of certain distributions of each of these limited partnerships. Mr. Steel does not have voting or dispositive control with respect to the securities held by either of these limited partnerships. Mr. Steel is also a director of ZP Holdings.

 

    M. James Barrett is one of seven Managers of a limited liability company that is the sole general partner of a limited partnership that is the sole general partner of limited partnership that owns outstanding common stock of ZP Holdings. Dr. Barrett disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein, if any. Dr. Barrett also owns shares of common stock of ZP Holdings and is a director of ZP Holdings.

 

    John Richard is an operating partner and non-executive director of an entity that is both (i) the manager of a limited partnership that owns outstanding common stock of ZP Holdings and (ii) the sole shareholder of an entity that is the general partner of the limited partnership that owns outstanding common stock of ZP Holdings. Mr. Richard disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein, if any. Mr. Richard also owns shares of, and holds an option to acquire shares of, common stock of ZP Holdings and is a director of ZP Holdings.

 

    Each of Peter Daddona and Vikram Lamba owns shares of common stock of ZP Holdings and holds an option to acquire shares of common stock of ZP Holdings. Each of Peter Daddona and Vikram Lamba is also an executive officer and a director of ZP Holdings.

 

    Each of Kleanthis Xanthopoulos and Christopher Krueger holds an option to acquire shares of common stock of ZP Holdings. Dr. Xanthopoulos is a director of ZP Holdings and Christopher Krueger is an executive officer of ZP Holdings.

 

8


The following is a description of arrangements between us, our promoters and those acquiring control of us pursuant to the Change in Control Transaction. The Company was incorporated in Delaware in September 2011 as Eco Planet Corp. In connection with its incorporation, Ms. Elka Yaron was appointed the sole director of Eco Planet Corp., and in such capacity Ms. Yaron (i) appointed herself as President and Treasurer of Eco Planet Corp. and (ii) appointed Mr. Aharon Shnitzer as Secretary and as a director of Eco Planet Corp. On September 21, 2011, Eco Planet Corp. issued 1,200,000 shares of Common Stock to Ms. Yaron and 500,000 shares of Common Stock to Mr. Shnitzer, in exchange for an aggregate payment of $20,400 (or $0.012 per share). In May 2012, Eco Planet Corp. sold an aggregate of 304,613 newly issued shares of Common Stock to outside investors at a purchase price of $0.15 per share, pursuant to a Registration Statement on Form S-1. The foregoing numbers of shares of Common Stock have not been adjusted to reflect the reverse stock split of the Common Stock described in the immediately following paragraph.

On October 21, 2013, we effected a 1-for-200 reverse stock split of our Common Stock (the “Reverse Split”) and changed our name to “Zosano, Inc.” As a result of the Company’s issuance and sale of the Shares to ZP Holdings pursuant to the Purchase Agreement, ZP Holdings became the owner of 99.9% of our outstanding Common Stock. In connection with the closing of the transactions under the Purchase Agreement, we declared a cash dividend on our Common Stock, payable to the stockholders of record as of immediately prior to the closing. This special dividend consisted of an aggregate of $365,000 less the amount equal to all of our liabilities as they existed at the closing of the transactions under the Purchase Agreement.

As a result of the Change in Control Transaction, we have six directors serving on our Board of Directors. Our securities are not listed on any national securities exchange and therefore we are not subject to any director independence standards. Using the definition of independence set forth in the rules of the NASDAQ Stock Market, our Board of Directors has determined that Kleanthis Xanthopoulos is independent, and Vikram Lamba, Peter Daddona, John Richard, Bruce Steel, and M. James Barrett are not independent. In making that determination, the Board of Directors considered the relationships that each such person has with our Company and all other facts and circumstances that the board considered relevant, including the ownership of our Common Stock.

The following information regarding our Common Stock is provided in response to Item 9 of Form 10. The Common Stock is eligible for quotation on the OTC Markets Group’s OTCQB market tier under the symbol “EPLCD.” To date, 1,000 shares of our Common Stock traded during the quarter ended September 30, 2012, 500 of which traded at $0.25 per share and 500 of which traded at $0.70 per share, and 500 shares of our Common Stock traded during the quarter ended September 30, 2013 at $0.70 per share. The foregoing numbers of shares of Common Stock and corresponding prices have not been adjusted to reflect the Reverse Split. In connection with the Change in Control Transaction, we applied to change the trading symbol of the Common Stock from “EPLC” to “ZOSN” with the Financial Industry Regulatory Authority, Inc. We have been notified that our application has been approved, and that the Common Stock will be eligible for quotation on OTCQB under the symbol “ZOSN” commencing on November 19, 2013. Until November 19, 2013, our Common Stock will be eligible for quotation under the symbol “EPLCD.”

 

9


The number of holders of record of our Common Stock as of October 31, 2013, after giving effect to the issuance and sale of the Shares to ZP Holdings pursuant to the Purchase Agreement, was 47. This number does not include an undetermined number of stockholders whose stock is held in “street” or “nominee” name. Except for the cash dividend declared in connection with the closing of the transactions under the Purchase Agreement, as described above in response to Item 7 of Form 10, we have not declared or paid any cash dividends or distributions on our capital stock. We currently intend to retain our future earnings, if any, to support operations and to finance expansion and we do not anticipate paying any cash dividends on our Common Stock in the foreseeable future.

The information required by Item 12 of Form 10 is incorporated herein by reference to the section of Part II of the Company’s Registration Statement on Form S-1/A filed on May 2, 2012 titled “Indemnification of Directors, Officers, Employees and Agents,” as supplemented by the following information. Each of our current directors is party to an indemnification agreement between such individual and ZP Holdings, which provides the individual with indemnification in addition to the indemnification provided for in our bylaws. Each of these agreements provides, among other things, that ZP Holdings will indemnify the individual to the fullest extent permitted by law for certain expenses (including attorneys’ fees), judgments, fines, penalties and settlement amounts incurred by the individual in any action or proceeding arising out of such individual’s status as a director, officer, employee, agent or fiduciary of any other corporation or enterprise at ZP Holdings’ request.

In response to Item 14 of Form 10, during our two most recent fiscal years ended December 31, 2012 and 2011 and in the subsequent interim period, there were no disagreements, resolved or not, with Weinberg & Baer LLC on any matter of accounting principles or practices, financial statement disclosure, or audit scope and procedures, which disagreement(s), if not resolved to the satisfaction of Weinberg & Baer LLC would have caused such accounting firm to make reference to the subject matter of the disagreement(s) in connection with its report.

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

The directors of the Company prior to the closing of the transactions under the Purchase Agreement, Elka Yaron and Aharon Shnitzer, resigned as directors effective upon the closing, and our new directors, as set forth in Item 5.01 of this Current Report on Form 8-K, were appointed effective as of the closing of the transactions under the Purchase Agreement. Similarly, the sole executive officer of the Company, Elka Yaron, tendered her resignation effective upon the closing of the transactions under the Purchase Agreement, and our new executive officers, as set forth in Item 5.01 of this Current Report on Form 8-K, were appointed effective as of the closing of the transactions under the Purchase Agreement. For certain biographical and other information regarding the newly appointed officers and directors, see the corresponding disclosure under Item 5.01 of this Current Report on Form 8-K, which disclosure is incorporated herein by reference.

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

On September 17, 2013, stockholders of the Company holding approximately 85% of the issued and outstanding shares of our Common Stock executed a written consent in lieu of a meeting of stockholders, pursuant to which the stockholders approved the amendment and restatement of our certificate of incorporation effecting the Reverse Split, the change of our

 

10


corporate name from “Eco Planet Corp.” to “Zosano, Inc.,” the creation of staggered terms for the members of our Board of Directors, a limitation on the liability of the members of our Board of Directors to the maximum extent permitted under Delaware law, and a requirement that certain stockholder actions may only be taken with a supermajority vote of the holders of more than two thirds of our voting stock.

On September 30, 2013, stockholders of the Company holding approximately 85% of the issued and outstanding shares of our Common Stock executed a written consent in lieu of a meeting of stockholders, pursuant to which the stockholders approved an amendment to our amended and restated certificate of incorporation changing the effective time of our amended and restated certificate of incorporation from October 2, 2013 to October 11, 2013.

On October 10, 2013, stockholders of the Company holding approximately 85% of the issued and outstanding shares of our Common Stock executed a written consent in lieu of a meeting of stockholders, pursuant to which the stockholders approved an amendment to our amended and restated certificate of incorporation, as amended, changing the effective time of our amended and restated certificate of incorporation, as amended, from October 11, 2013 to October 21, 2013.

On October 17, 2013, stockholders of the Company holding approximately 85% of the issued and outstanding shares of our Common Stock executed a written consent in lieu of a meeting of stockholders, pursuant to which the stockholders approved an amendment to our amended and restated certificate of incorporation, as amended, deleting in their entirety the sections of our amended and restated certificate of incorporation providing (i) that no action shall be taken by the Company’s stockholders by written consent or electronic transmission, and (ii) that advance notice of stockholder nominations for the election of directors and of business to be brought by stockholders before any meeting of the Company’s stockholders shall be given in the manner provided in the Company’s bylaws.

On October 30, 2013, stockholders of the Company holding approximately 85% of the issued and outstanding shares of our Common Stock executed a written consent in lieu of a meeting of stockholders, pursuant to which the stockholders approved the Company’s issuance and sale of the Shares to ZP Holdings pursuant to the Purchase Agreement.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits .

 

Exhibit    Description
  3.1    Amended and Restated Certificate of Incorporation of Zosano, Inc.
  3.2    Certificate of Amendment to Amended and Restated Certificate of Incorporation of Zosano, Inc.
  3.3    Certificate of Amendment to Amended and Restated Certificate of Incorporation of Zosano, Inc.
  3.4    Certificate of Amendment to Amended and Restated Certificate of Incorporation of Zosano, Inc.
  3.5    Bylaws of Zosano, Inc. (filed on January 23, 2012 as Exhibit 3.2 to the Registration Statement on Form S-1 and incorporated herein by reference)
10.1    Stock Purchase Agreement dated as of October 31, 2013 by and between Zosano, Inc. and ZP Holdings, Inc.

 

11


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    ZOSANO, INC.
Dated: November 6, 2013     By:   /s/ Vikram Lamba
      Vikram Lamba
      President

 

12


EXHIBIT INDEX

 

Exhibit    Description
  3.1    Amended and Restated Certificate of Incorporation of Zosano, Inc.
  3.2    Certificate of Amendment to Amended and Restated Certificate of Incorporation of Zosano, Inc.
  3.3    Certificate of Amendment to Amended and Restated Certificate of Incorporation of Zosano, Inc.
  3.4    Certificate of Amendment to Amended and Restated Certificate of Incorporation of Zosano, Inc.
  3.5    Bylaws of Zosano, Inc. (filed on January 23, 2012 as Exhibit 3.2 to the Registration Statement on Form S-1 and incorporated herein by reference)
10.1    Stock Purchase Agreement dated as of October 31, 2013 by and between Zosano, Inc. and ZP Holdings, Inc.

 

13

Exhibit 3.1

AMENDED AND RESTATED

CERTIFICATE OF INCORPORATION

OF

ECO PLANET CORP.

Pursuant to Section 242 and Section 245 of the General Corporation Law of the State of Delaware, Eco Planet Corp. has adopted this Amended and Restated Certificate of Incorporation amending and restating its Certificate of Incorporation (originally filed September 14, 2011), which Amended and Restated Certificate of Incorporation has been duly proposed by the directors and adopted by the stockholders of this corporation (by written consent pursuant to Section 228 of said General Corporation Law) in accordance with the provisions of said Section 242 and Section 245.

I.

The name of this corporation is Zosano, Inc.

II.

The address of the registered office of the corporation in the State of Delaware is 1811 Silverside Road, Wilmington, County of New Castle, Delaware 19810, and the name of the registered agent of the corporation in the State of Delaware at such address is Vcorp Services, LLC.

III.

The purpose of this corporation is to engage in any lawful act or activity for which a corporation may be organized under the Delaware General Corporation Law (“ DGCL ”).

IV.

A. This corporation is authorized to issue two classes of stock to be designated, respectively, “ Common Stock ” and “ Preferred Stock .” The total number of shares which the corporation is authorized to issue is two hundred million (200,000,000) shares. One hundred ninety five million (195,000,000) shares shall be Common Stock, each having a par value of one-hundreth of one cent ($0.0001) (“ Common Stock ”). Five million (5,000,000) shares shall be Preferred Stock, each having a par value of one-hundreth of one cent ($0.0001) (“ Preferred Stock ”).

At the time this Amended and Restated Certificate of Incorporation becomes effective (the “ Effective Time ”), the outstanding shares of the corporation’s capital stock shall be combined such that each two hundred (200) shares of common stock, $0.0001 par value per share, of the corporation outstanding at the Effective Time (“ Old Common Stock ”) shall automatically be changed into one (1) fully paid and nonassessable share of Common Stock without any action on the part of the holder thereof (the “ Reverse Stock Split ”). All shares of Common Stock issued to any holder of Old Common Stock as a result of the Reverse Stock Split shall be aggregated for the purpose of determining the number of shares of Common Stock to which such holder shall be entitled, and any fractional share that any stockholder would


otherwise be entitled to receive in connection with the Reverse Stock Split following such aggregation shall be rounded up to the nearest whole share. At and after the Effective Time, each outstanding certificate that prior thereto represented shares of Old Common Stock shall be deemed for all purposes to evidence ownership of and to represent that whole number of shares of Common Stock into which the shares represented by such certificate shall have been combined, reclassified and changed as herein provided. Until any such outstanding stock certificate shall have been surrendered for transfer or otherwise accounted for to the corporation, the registered owner thereof on the books and records of the corporation shall have and be entitled to exercise any voting and other rights with respect to, and to receive any dividend and other distributions upon, the shares of Common Stock issuable to the holder thereof upon surrender of such certificate.

B. The Preferred Stock may be issued from time to time in one or more series. The Board of Directors is hereby expressly authorized to provide for the issue of all or any of the shares of the Preferred Stock in one or more series, and to fix the number of shares and to determine or alter for each such series, such voting powers, if any, and such designation, preferences, and relative, participating, optional, or other rights and such qualifications, limitations, or restrictions thereof, as shall be stated and expressed in the resolution or resolutions adopted by the Board of Directors providing for the issuance of such shares and as may be permitted by the DGCL. The Board of Directors is also expressly authorized to increase or decrease the number of shares of any series subsequent to the issuance of shares of that series, but not below the number of shares of such series then outstanding. In case the number of shares of any series shall be decreased in accordance with the foregoing sentence, the shares constituting such decrease shall resume the status that they had prior to the adoption of the resolution originally fixing the number of shares of such series.

C. Each outstanding share of Common Stock shall entitle the holder thereof to one vote on each matter properly submitted to the stockholders of the corporation for their vote; provided, however , that, except as otherwise required by law, holders of Common Stock shall not be entitled to vote on any amendment to this Amended and Restated Certificate of Incorporation (including any certificate of designation filed with respect to any series of Preferred Stock) that relates solely to the terms of one or more outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or together as a class with the holders of one or more other such series, to vote thereon by law or pursuant to this Amended and Restated Certificate of Incorporation (including any certificate of designation filed with respect to any series of Preferred Stock).

V.

For the management of the business and for the conduct of the affairs of the corporation, and in further definition, limitation and regulation of the powers of the corporation, of its directors and of its stockholders or any class thereof, as the case may be, it is further provided that:

 

- 2 -


A. B OARD OF D IRECTORS

1. The management of the business and the conduct of the affairs of the corporation shall be vested in its Board of Directors. The number of directors constituting the Board of Directors shall be fixed from time to time, exclusively by resolutions adopted by a majority of the authorized number of directors constituting the Board of Directors.

2. Subject to the rights of the holders of any series of Preferred Stock to elect additional directors under specified circumstances, the directors shall be divided into three classes designated as Class I, Class II and Class III, respectively. The Board of Directors is authorized to assign members of the Board of Directors already in office to such classes at the time the classification becomes effective. At the first annual meeting of stockholders following the initial classification of the Board of Directors, the term of office of the Class I directors shall expire and Class I directors shall be elected for a full term of three years. At the second annual meeting of stockholders following such initial classification, the term of office of the Class II directors shall expire and Class II directors shall be elected for a full term of three years. At the third annual meeting of stockholders following such initial classification, the term of office of the Class III directors shall expire and Class III directors shall be elected for a full term of three years. At each succeeding annual meeting of stockholders, directors shall be elected for a full term of three years to succeed the directors of the class whose terms expire at such annual meeting.

Notwithstanding the foregoing provisions of this section, each director shall hold office until such director’s successor is duly elected and qualified or until such director’s earlier death, resignation or removal. No decrease in the number of directors constituting the Board of Directors shall shorten the term of any incumbent director.

3. R EMOVAL OF D IRECTORS ; V ACANCIES

a.  Subject to the rights of any series of Preferred Stock to elect additional directors under specified circumstances, neither the Board of Directors nor any individual director may be removed without cause.

b.  Subject to any limitation imposed by law, any individual director or directors may be removed with cause by the affirmative vote of the holders of at least sixty-six and two-thirds percent (66  2 3 %) of the voting power of all then-outstanding shares of capital stock of the corporation entitled to vote generally in the election of directors.

4. Subject to the rights of the holders of any series of Preferred Stock, any vacancies on the Board of Directors resulting from death, resignation, disqualification, removal or other causes and any newly created directorships resulting from any increase in the number of directors, shall, except as otherwise provided by law, be filled only by the affirmative vote of a majority of the directors then in office, even though less than a quorum of the Board of Directors, and not by the stockholders, unless the Board of Directors determines by resolution that any such vacancies or newly created directorships shall be filled by the stockholders. Any director elected in accordance with the preceding sentence shall hold office for the remainder of the full term of the director for which the vacancy was created or occurred and until such director’s successor shall have been elected and qualified.

 

- 3 -


B.

1. The Board of Directors is expressly empowered to adopt, amend or repeal the Bylaws of the corporation. Any adoption, amendment or repeal of the Bylaws of the corporation by the Board of Directors shall require the approval of a majority of the authorized number of directors. The stockholders shall also have power to adopt, amend or repeal the Bylaws of the corporation; provided that , in addition to any vote of the holders of any class or series of stock of the corporation required by law or by this Amended and Restated Certificate of Incorporation, such action by stockholders shall require the affirmative vote of the holders of at least sixty-six and two-thirds percent (66  2 3 %) of the voting power of all of the then-outstanding shares of the capital stock of the corporation entitled to vote generally in the election of directors, voting together as a single class.

2. The directors of the corporation need not be elected by written ballot unless the Bylaws so provide.

3. No action shall be taken by the stockholders of the corporation except at an annual or special meeting of stockholders called in accordance with the Bylaws, and no action shall be taken by the stockholders by written consent or electronic transmission.

4. Advance notice of stockholder nominations for the election of directors and of business to be brought by stockholders before any meeting of the stockholders of the corporation shall be given in the manner provided in the Bylaws of the corporation.

VI.

A. The liability of the directors for monetary damages shall be eliminated to the fullest extent under applicable law. If the DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director of the corporation shall be eliminated to the fullest extent permitted by the DGCL, as so amended.

B. Any repeal or modification of this Article VI shall be prospective and shall not affect the rights under this Article VI in effect at the time of the alleged occurrence of any act or omission to act giving rise to liability or indemnification.

VII.

A. The corporation reserves the right to amend, alter, change or repeal any provision contained in this Amended and Restated Certificate of Incorporation, in the manner now or hereafter prescribed by statute, except as provided in paragraph C of this Article VII, and all rights conferred upon the stockholders herein are granted subject to this reservation.

B. Unless the corporation consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the corporation, (ii) any action asserting a claim for breach of a fiduciary duty owed by any director, officer, employee or agent of the corporation to the corporation or the corporation’s stockholders, (iii) any action asserting a claim arising pursuant to any provision of the DGCL, this Certificate of Incorporation or the Bylaws of

 

- 4 -


the corporation or (iv) any action asserting a claim governed by the internal affairs doctrine, in each case subject to said Court of Chancery having personal jurisdiction over the indispensable parties named as defendants therein.

C. Notwithstanding any other provisions of this Amended and Restated Certificate of Incorporation or any provision of law that might otherwise permit a lesser vote or no vote, but in addition to any affirmative vote of the holders of any particular class or series of the corporation required by law or by this Amended and Restated Certificate of Incorporation or any certificate of designation filed with respect to a series of Preferred Stock, the affirmative vote of the holders of at least sixty-six and two-thirds percent (66  2 3 %) of the voting power of all of the then-outstanding shares of capital stock of the corporation entitled to vote generally in the election of directors, voting together as a single class, shall be required to alter, amend or repeal Articles V, VI and VII.

VIII.

This Amended and Restated Certificate of Incorporation shall be effective on October 2, 2013 at 10:00 a.m. EDT.

[remainder of page is intentionally blank; signature page follows]

 

- 5 -


I N W ITNESS W HEREOF , this Amended and Restated Certificate of Incorporation has been executed by a duly authorized officer of this corporation on this 17th day of September, 2013.

 

By:   /s/ Elka Yaron
  Elka Yaron, President

Exhibit 3.2

CERTIFICATE OF AMENDMENT

TO

AMENDED AND RESTATED

CERTIFICATE OF INCORPORATION

OF

ECO PLANET CORP.

ECO PLANET CORP. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, DOES HEREBY CERTIFY:

FIRST: Pursuant to Unanimous Written Consent of the Directors of the Corporation on September 30, 2013, a new effective date for the Amended and Restated Certificate of Incorporation of the Corporation filed with the State of Delaware on September 24, 2013 was approved as set forth herein.

SECOND: That the new effective time and date for the above-mentioned Amended and Restated Certificate of Incorporation has been consented to and authorized by the holders of a majority of the issued and outstanding stock of the Corporation entitled to vote thereon, by written consent in lieu of meeting in accordance with Section 228 of the General Corporation Law of the State of Delaware.

THIRD: That the aforesaid amendment was duly adopted in accordance with the applicable provisions of Section 242 of the General Corporation Law of the State of Delaware.

FOURTH : The Amended and Restated Certificate of Incorporation filed by the Corporation on September 24, 2013 shall be effective as of 10:00 a.m. Eastern Daylight Time on October 11, 2013.

IN WITNESS WHEREOF, said Corporation has caused this certificate to be signed this 30th day of September, 2013.

 

By:   /s/ Elka Yaron
  Elka Yaron,
  President

Exhibit 3.3

CERTIFICATE OF AMENDMENT

TO

AMENDED AND RESTATED

CERTIFICATE OF INCORPORATION

OF

ECO PLANET CORP.

ECO PLANET CORP. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, DOES HEREBY CERTIFY:

FIRST: Pursuant to Unanimous Written Consent of the Directors of the Corporation on October 10, 2013, a new effective date for the Amended and Restated Certificate of Incorporation of the Corporation filed with the State of Delaware on September 24, 2013, as amended by the Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Corporation filed with the State of Delaware on October 1, 2013 (as so amended, the “Amended and Restated Certificate of Incorporation”), was approved as set forth herein.

SECOND: That the new effective time and date for the Amended and Restated Certificate of Incorporation has been consented to and authorized by the holders of a majority of the issued and outstanding stock of the Corporation entitled to vote thereon, by written consent in lieu of meeting in accordance with Section 228 of the General Corporation Law of the State of Delaware.

THIRD: That the aforesaid amendment was duly adopted in accordance with the applicable provisions of Section 242 of the General Corporation Law of the State of Delaware.

FOURTH : The Amended and Restated Certificate of Incorporation shall be effective as of 1:00 p.m. Eastern Daylight Time on October 21, 2013.

IN WITNESS WHEREOF, said Corporation has caused this certificate to be signed this 10th day of October, 2013.

 

By:   /s/ Elka Yaron
  Elka Yaron,
  President

Exhibit 3.4

CERTIFICATE OF AMENDMENT

TO

AMENDED AND RESTATED

CERTIFICATE OF INCORPORATION

OF

ZOSANO INC.

ZOSANO, INC. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, DOES HEREBY CERTIFY:

FIRST: That the Board of Directors of the Corporation, by unanimous written consent, adopted resolutions proposing and declaring advisable that the Amended and Restated Certificate of Incorporation of the Corporation filed with the State of Delaware on September 24, 2013, as amended by the Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Corporation filed with the State of Delaware on October 1, 2013 and the Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Corporation filed with the State of Delaware on October 11, 2013, which is set to go effective on October 21, 2013 at 1 p.m. Eastern Daylight Time (as so amended, the “Amended and Restated Certificate of Incorporation”), be further amended and that such amendment be submitted to the stockholders of the Corporation for their consideration, as follows:

 

  (i) Article V, Section B.3 of the Amended and Restated Certificate of Incorporation is amended by deleting Section B.3 in its entirety and replacing it with the following new Section B.3:

 

  3. [Intentionally omitted.]”

 

  (ii) Article V, Section B.4 of the Amended and Restated Certificate of Incorporation is amended by deleting Section B.4 in its entirety and replacing it with the following new Section B.4:

 

  4. [Intentionally omitted.]”

SECOND: That the aforesaid amendment to the Amended and Restated Certificate of Incorporation has been consented to and authorized by the holders of a majority of the issued and outstanding stock of the Corporation entitled to vote thereon, by written consent in lieu of meeting in accordance with Section 228 of the General Corporation Law of the State of Delaware.

THIRD: That the aforesaid amendment was duly adopted in accordance with the applicable provisions of Section 242 of the General Corporation Law of the State of Delaware.

FOURTH: This Certificate of Amendment shall be effective at 1:00 p.m. Eastern Daylight Time on October 21, 2013.

IN WITNESS WHEREOF, said Corporation has caused this certificate to be signed this 17th day of October, 2013.

 

By:   /s/ Elka Yaron
  Elka Yaron,
  President

Exhibit 10.1

STOCK PURCHASE AGREEMENT

by and between

ZOSANO, INC.

and

ZP HOLDINGS, INC.

October 31, 2013


TABLE OF CONTENTS

 

         Page  
Article I DEFINITIONS      1   

Article II PURCHASE AND SALE OF COMMON STOCK

     3   

2.1

  Sale and Issuance of Common Stock      3   

2.2

  Closing      4   

Article III REPRESENTATIONS AND WARRANTIES OF BUYER

     4   

3.1

  Organization and Qualification      4   

3.2

  Authority Relative to this Agreement; Non-Contravention      4   

3.3

  No Conflicts      5   

3.4

  Purchase for Own Account      5   

3.5

  Disclosure of Information      5   

3.6

  Restricted Securities      5   

3.7

  Accredited Investor      6   

3.8

  No General Solicitation      6   

Article IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY

     6   

4.1

  Organization and Qualification      6   

4.2

  Authority Relative to this Agreement; Non-Contravention      7   

4.3

  No Conflicts      7   

4.4

  Capitalization      7   

4.5

  Validity of the Shares      8   

4.6

  Exchange Act Reports; Financial Statements      8   

4.7

  Litigation      9   

4.8

  No Brokers or Finders      9   

4.9

  Tax Matters      9   

4.10

  Contracts and Commitments      11   

4.11

  Affiliate Transactions      11   

4.12

  Compliance with Laws; Permits      11   

4.13

  Books and Records      12   

4.14

  Real Property      12   

4.15

  Insurance      12   

4.16

  No Undisclosed Liabilities      12   

4.17

  Environmental Matters      12   

4.18

  Absence of Certain Developments      12   

4.19

  Employee Benefit Plans      13   

4.20

  Employees      13   

4.21

  Proprietary Information and Inventions      13   

4.22

  Intellectual Property      14   

 

i


4.23

  Investment Company      14   

4.24

  Foreign Corrupt Practices      14   

4.25

  No Integrated Offering      14   

4.26

  Application of Takeover Provisions      14   

4.27

  Information      15   

4.28

  Full Disclosure      15   

Article V ADDITIONAL COVENANTS AND AGREEMENTS

     15   

5.1

  Further Assurances; Governmental Filings      15   

5.2

  Expenses      15   

5.3

  Private Placement      15   

Article VI CONDITIONS

     16   

6.1

  Conditions to Obligation of the Company      16   

6.2

  Conditions to Obligation of Buyer      16   

Article VII GENERAL PROVISIONS

     18   

7.1

  Notices      18   

7.2

  No Survival      19   

7.3

  Interpretation      19   

7.4

  Severability      19   

7.5

  Amendment      20   

7.6

  Waiver      20   

7.7

  Miscellaneous      20   

7.8

  Counterparts; Facsimile Signatures      20   

7.9

  Third Party Beneficiaries      20   

7.10

  Governing Law      20   

7.11

  Jurisdiction; Service of Process      20   

7.12

  Waiver of Jury Trial      20   

7.13

  Disclosure in Schedules      21   

SCHEDULES

Schedule 4.4(b) — Holders of Company Common Stock

Schedule 4.8 — Brokers and Finders

 

ii


STOCK PURCHASE AGREEMENT

This Stock Purchase Agreement (this “ Agreement ”) is entered into as of October 31, 2013, by and between Zosano, Inc., a Delaware corporation formerly named Eco Planet Corp. (the “ Company ”), and ZP Holdings, Inc., a Delaware corporation (“ Buyer ”).

In consideration of the representations, warranties and covenants contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

ARTICLE I

DEFINITIONS

As used herein, the following terms shall have the following meanings (such meanings to be equally applicable to both the singular and plural forms of the terms defined):

Affiliate ” shall have the meaning ascribed to such term in Rule 12b-2 promulgated under the Exchange Act, as such regulation is in effect on the date hereof.

Amended and Restated Term Sheet ” shall have the meaning set forth in Section 2.1(b).

Board of Directors ” shall mean the board of directors of the entity specified.

Closing ” shall have the meaning set forth in Section 2.2.

Closing Date ” shall have the meaning set forth in Section 2.2.

Code ” shall mean the Internal Revenue Code of 1986, as amended.

Company Charter Amendments ” shall mean, collectively, the Amended and Restated Certificate of Incorporation of the Company filed with the Secretary of State of the State of Delaware on September 24, 2013, the Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company filed with the Secretary of State of the State of Delaware on October 1, 2013, the Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company filed with the Secretary of State of the State of Delaware on October 11, 2013, and the Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company filed with the Secretary of State of the State of Delaware on October 17, 2013.

Company Common Stock ” shall have the meaning set forth in Section 2.1(a).

Company Financial Statements ” shall have the meaning set forth in Section 4.6(c).

Company Form S-1 ” shall have the meaning set forth in Section 4.6(a).

Company Insiders ” shall have the meaning set forth in Section 4.11.

Company Latest Balance Sheet ” shall have the meaning set forth in Section 4.16.


Company SEC Filings ” shall have the meaning set forth in Section 4.6(a).

Compensatory Plan ” shall mean (i) any employment, consulting, noncompetition, nondisclosure, nonsolicitation, severance, termination, pension, retirement, supplemental retirement, excess benefit, profit sharing, bonus, incentive, deferred compensation, retention, change in control or similar plan, program, arrangement, agreement, policy or commitment, (ii) any compensatory equity interest, stock option, restricted stock, deferred stock, performance stock, stock appreciation, stock unit or other equity or equity-based plan, program, arrangement, agreement, policy or commitment, (iii) any savings, life, health, disability, accident, medical, dental, vision, cafeteria, insurance, flex spending, adoption/dependent/employee assistance, tuition, vacation, paid-time-off, other welfare fringe benefit or other employee compensation plan, program, arrangement, agreement, policy or commitment, including any “employee benefit plan” as defined in Section 3(3) of ERISA, and (iv) any trust, escrow, funding, insurance or other agreement related to any of the foregoing, in each case, to, under or with respect to which the Company has any actual or contingent obligation or liability.

ERISA ” shall mean the Employee Retirement Income Security Act of 1974, as amended, or any successor law and the rules and regulations promulgated thereunder.

ERISA Affiliate ” shall mean any entity which is (or at any relevant time was), with the Company, a member of a “controlled group of corporations,” under “common control” with, or a member of an “affiliated service group,” within the meaning of Section 414(b), (c), (m) or (o) of the Code.

Escrow Agreement No. 1 ” shall mean that certain Escrow Agreement dated as of July 23, 2013 by and among the Company, Buyer and Anslow & Jaclin, LLP, as escrow agent, as amended by Amendment No. 1 to Escrow Agreement dated as of September 17, 2013 by and among the Company, Buyer and Szaferman Lakind Blumstein & Blader, PC, as successor escrow agent.

Escrow Agreement No. 2 ” shall mean that certain Escrow Agreement dated as of October 21, 2013 by and among the Company, Buyer and Szaferman Lakind Blumstein & Blader, PC, as escrow agent.

Exchange Act ” shall mean the Securities Exchange Act of 1934, as amended, including the rules and regulations promulgated thereunder.

Final Deposit ” shall have the meaning set forth in Section 2.1(b).

GAAP ” shall mean United States generally accepted accounting principles, as in effect from time to time.

Initial Deposit ” shall have the meaning set forth in Section 2.1(b).

Knowledge ” shall mean, with respect to an individual, that such individual is actually aware of a particular fact or other matter, with no obligation to conduct any inquiry or other investigation to determine the accuracy of such fact or other matter. A Person other than an individual shall be deemed to have Knowledge of a particular fact or other matter if the officers,

 

2


directors or other management personnel of such Person had Knowledge of such fact or other matter.

Material Adverse Effect ” shall mean, with respect to an entity, a material adverse effect on the business, operations, results of operations or financial condition of such entity on a consolidated basis.

Original Term Sheet ” shall have the meaning set forth in Section 2.1(b).

Person ” shall mean any individual, corporation (including any non-profit corporation), general or limited partnership, limited liability company, joint venture, estate, trust, association, organization, labor union, governmental authority or other entity.

Purchase Price ” shall have the meaning set forth in Section 2.1(a).

Requisite Company Stockholder Vote ” shall have the meaning set forth in Section 4.2.

Returns ” shall have the meaning set forth in Section 4.9(a).

SEC ” shall mean the United States Securities and Exchange Commission.

Securities Act ” shall mean the Securities Act of 1933, as amended, including the rules and regulations promulgated thereunder.

Shares ” shall have the meaning set forth in Section 2.1(a).

Subsidiary ” shall mean, with respect to any Person, (i) each corporation of which such Person owns directly or indirectly fifty percent (50%) or more of the voting securities and (ii) any other Person of which such Person owns at least a majority voting interest, and shall, in each case, unless otherwise indicated, be deemed to refer to both direct and indirect subsidiaries of such Person.

Tax ” or “ Taxes ” (and, with correlative meaning, “ Taxable ” and “ Taxing ”) shall mean any federal, state, local or foreign income, gross receipts, license, payroll, employment, excise, severance, stamp, occupation, premium, property or windfall profits taxes, environmental taxes, customs duties, capital stock, franchise, employees’ income withholding, foreign or domestic withholding, social security, unemployment, disability, workers’ compensation, employment-related insurance, real property, personal property, sales, use, transfer, value added, alternative or add-on minimum or other governmental tax, fee, assessment or charge of any kind whatsoever including any interest, penalties or additions to any Tax or additional amounts in respect of the foregoing.

ARTICLE II

PURCHASE AND SALE OF COMMON STOCK

2.1 Sale and Issuance of Common Stock.

 

3


(a) Subject to the terms and conditions of this Agreement, Buyer agrees to purchase at the Closing, and the Company agrees to sell and issue to Buyer at the Closing, 10,016,973 shares of the common stock, $0.0001 par value per share, of the Company (the “ Company Common Stock ”), for an aggregate purchase price of $365,000 (the “ Purchase Price ”). The shares of Company Common Stock issued to Buyer pursuant to this Agreement shall be referred to in this Agreement as the “ Shares .” At the Closing, the Company shall deliver to Buyer a certificate representing the Shares against payment of the Purchase Price, in accordance with Section 2.1(b).

(b) The Company and Buyer acknowledge and agree that the Company has, (i) pursuant to the Term Sheet dated July 23, 2013 between the Company and Buyer, as amended by Amendment No. 1 to Term Sheet dated as of September 17, 2013 between the Company and Buyer (as so amended, the “ Original Term Sheet ”), paid the Company a cash deposit in respect of the Purchase Price in the amount of $140,000 (the “ Initial Deposit ”), and (ii) pursuant to the Amended and Restated Term Sheet dated October 21, 2013 between the Company and Buyer (the “ Amended and Restated Term Sheet ”), paid the Company a cash deposit in respect of the Purchase Price in the amount of $225,000 (the “ Final Deposit ”). The Company and Buyer further acknowledge and agree that the Initial Deposit has been released to the Company prior to the date of this Agreement pursuant to the terms of Escrow Agreement No. 1 and shall be credited against the Purchase Price, and that the Final Deposit will be released to the Company upon the Closing pursuant to the terms of Escrow Agreement No. 2 and shall be credited against the Purchase Price. Accordingly, and for the avoidance of doubt, Buyer’s obligations to the Company in respect of the Purchase Price are hereby deemed fully paid, discharged and satisfied, and Buyer shall not be obligated to pay any additional amount to the Company in respect of the Purchase Price for the Shares.

2.2 Closing . Subject to the provisions of Article VI, the closing of the purchase and sale of the Shares (the “ Closing ”) shall take place or remotely via the exchange of documents and signatures on the date of this Agreement, or at such other time and/or place as the Company and Buyer mutually agree upon. As used herein, the term “ Closing Date ” shall mean the date on which the Closing occurs.

ARTICLE III

REPRESENTATIONS AND WARRANTIES OF BUYER

Buyer hereby represents and warrants to the Company as follows:

3.1 Organization and Qualification . Buyer is, and on the Closing Date will be, a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware, and has, and on the Closing Date will have, the requisite corporate power to carry on its business as now conducted. Buyer is, and on the Closing Date will be, licensed or qualified to do business in every jurisdiction in which the nature of its business or its ownership of property requires it to be licensed or qualified, except where the failure to be so licensed or qualified would not have a Material Adverse Effect on Buyer.

3.2 Authority Relative to this Agreement; Non-Contravention . Buyer has the requisite corporate power and authority to enter into this Agreement and to carry out its

 

4


obligations hereunder. The execution and delivery of this Agreement by Buyer and the consummation by Buyer of the transactions contemplated hereby have been duly authorized by all necessary corporate proceedings on the part of Buyer. This Agreement has been duly executed and delivered by Buyer and, assuming it is a valid and binding obligation of the Company, constitutes a valid and binding obligation of Buyer enforceable in accordance with its terms, except as enforcement may be limited by general principles of equity, whether applied in a court of law or a court of equity, and by bankruptcy, insolvency and similar laws affecting creditors’ rights and remedies generally. No authorization, consent or approval of, or filing with, any public body, court or authority is necessary on the part of Buyer for the consummation by Buyer of the transactions contemplated by this Agreement, except for such authorizations, consents, approvals and filings as to which the failure to obtain or make the same would not, in the aggregate, reasonably be expected to have a Material Adverse Effect on Buyer, or adversely affect the consummation of the transactions contemplated hereby.

3.3 No Conflicts . Buyer is not subject to, or obligated under, any provision of (a) its certificate of incorporation or bylaws, (b) any agreement, arrangement or understanding, (c) any license, franchise or permit or (d) any law, regulation, order, judgment or decree, which would conflict with, be breached or violated, or in respect of which a right of termination or acceleration or any security interest, charge or encumbrance on any of its assets would be created, by the execution, delivery or performance of this Agreement or the consummation of the transactions contemplated hereby, other than any such conflicts, breaches, violations, rights of termination or acceleration or security interests, charges or encumbrances for which consents or waivers have been obtained or which, in the aggregate, would not reasonably be expected to result in a Material Adverse Effect on Buyer.

3.4 Purchase for Own Account . This Agreement is made with Buyer in reliance upon Buyer’s representation to the Company, which by Buyer’s execution of this Agreement Buyer hereby confirms, that the Shares to be acquired by Buyer will be acquired for investment for Buyer’s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and that Buyer has no present intention of selling, granting any participation in, or otherwise distributing the same. By executing this Agreement, Buyer further represents that Buyer does not presently have any contract, undertaking, agreement or arrangement with any Person to sell, transfer or grant participations to such Person or to any third Person, with respect to any of the Shares. Buyer has not been formed for the specific purpose of acquiring the Shares.

3.5 Disclosure of Information . Buyer has had an opportunity to discuss the Company’s business, management, financial affairs and the terms and conditions of the offering of the Shares with the Company’s management. The foregoing, however, does not limit or modify the representations and warranties of the Company in Article IV of this Agreement or the right of Buyer to rely thereon.

3.6 Restricted Securities . Buyer understands that the Shares have not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act. Buyer understands that the Shares are “restricted securities” under applicable U.S. federal and state securities laws and that, pursuant to these laws, Buyer must hold the Shares indefinitely unless they are registered with the SEC and

 

5


qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Shares will not be transferable except (1) pursuant to an effective registration statement under the Securities Act or (2) upon receipt by the Company of a written opinion of counsel for the holder reasonably satisfactory to the Company to the effect that the proposed transfer is exempt from the registration requirements of the Securities Act and applicable state securities laws. Buyer acknowledges that the Company has no obligation to register or qualify the Shares for resale. Buyer further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and on requirements relating to the Company which are outside of Buyer’s control, and which the Company is under no obligation and may not be able to satisfy. Buyer understands that restrictive legends shall be placed on all certificates representing the Shares, substantially as follows:

“NO TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY BE MADE EXCEPT (A) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS IN EFFECT THEREUNDER AND ALL APPLICABLE STATE SECURITIES OR “BLUE SKY” LAWS (SUCH FEDERAL AND STATE LAWS, THE “SECURITIES LAWS”) OR (B) IF THE CORPORATION HAS BEEN FURNISHED WITH AN OPINION OF COUNSEL FOR THE HOLDER, WHICH OPINION AND COUNSEL SHALL BE REASONABLY SATISFACTORY TO THE CORPORATION, TO THE EFFECT THAT SUCH TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION IS EXEMPT FROM THE PROVISIONS OF THE SECURITIES LAWS.”

3.7 Accredited Investor . Buyer is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.

3.8 No General Solicitation . Neither Buyer nor any of its officers, directors, employees, agents or stockholders has either directly or indirectly, including through a broker or finder, engaged in any general solicitation or published any advertisement in connection with the offer and sale of the Shares.

ARTICLE IV

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

The Company hereby represents and warrants to Buyer as follows:

4.1 Organization and Qualification . The Company is, and on the Closing Date will be, a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware, and has, and on the Closing Date will have, the requisite corporate power to carry on its business as now conducted. The copies of the certificate of incorporation and bylaws of the Company that have been made available to Buyer on or prior to the date of this Agreement are correct and complete copies of such documents as in effect as of the date hereof, and shall be in effect on the Closing Date. The Company is, and on the Closing Date will be, licensed or

 

6


qualified to do business in every jurisdiction in which the nature of its business or its ownership of property requires it to be licensed or qualified, except where the failure to be so licensed or qualified would not have a Material Adverse Effect on the Company, individually or in the aggregate.

4.2 Authority Relative to this Agreement; Non-Contravention . The Company has the requisite corporate power and authority to enter into this Agreement and to carry out its obligations hereunder. The execution and delivery of this Agreement by the Company and the consummation by the Company of the transactions contemplated hereby have been duly authorized by the Board of Directors of the Company and by the affirmative vote of the holders of a majority of the issued and outstanding shares of Company Common Stock (the “ Requisite Company Stockholder Vote ”), and no other corporate proceedings on the part of the Company are necessary to authorize the execution and delivery of this Agreement and the consummation of the transactions contemplated hereby, or will otherwise be sought by the Company. This Agreement has been duly executed and delivered by the Company and, assuming it is a valid and binding obligation of Buyer, constitutes a valid and binding obligation of the Company enforceable in accordance with its terms, except as enforcement may be limited by general principles of equity, whether applied in a court of law or a court of equity, and by bankruptcy, insolvency and similar laws affecting creditors’ rights and remedies generally. Except for approvals under applicable Blue Sky laws and the filing of Form D with the SEC, no authorization, consent or approval of, or filing with, any public body, court or authority is necessary on the part of the Company for the consummation by the Company of the transactions contemplated by this Agreement, except for such authorizations, consents, approvals and filings as to which the failure to obtain or make the same would not, in the aggregate, reasonably be expected to have a Material Adverse Effect on the Company or adversely affect the consummation of the transactions contemplated hereby.

4.3 No Conflicts . The Company is not subject to, or obligated under, any provision of (a) its certificate of incorporation or bylaws, (b) any agreement, arrangement or understanding, (c) any license, franchise or permit, or (d) subject to obtaining the approvals referred to in Section 4.2, any law, regulation, order, judgment or decree which would conflict with, be breached or violated, or in respect of which a right of termination or acceleration or any security interest, charge or encumbrance on any of their respective assets would be created, by the execution, delivery or performance of this Agreement or the consummation of the transactions contemplated hereby, other than any such conflicts, breaches, violations, rights of termination or acceleration or security interests, charges or encumbrances which, in the aggregate, would not reasonably be expected to have a Material Adverse Effect on the Company.

4.4 Capitalization.

(a) As of the date hereof, the Company is, and as of immediately prior to the Closing will be, authorized to issue 195,000,000 shares of Company Common Stock and 5,000,000 shares of preferred stock, $0.0001 par value per share, of which 10,027 shares of Company Common Stock and no shares of preferred stock are and will be issued and outstanding. The issued and outstanding shares of capital stock of the Company are, and at the Closing will be, duly authorized, validly issued, fully paid and nonassessable, not issued in violation of any preemptive rights or any applicable law, and free from any restrictions on

 

7


transfer (other than restrictions under the Securities Act or state securities laws) or any option, lien, pledge, security interest, encumbrance, restriction or charge of any kind. Other than the Company Common Stock, the Company does not have, and at the Closing will not have, any other securities, including equity securities, securities containing any equity features or debt securities, authorized, issued or outstanding. The Company has not at any time granted any stock options, restricted stock, restricted stock units, phantom stock, performance stock or other compensatory equity or equity-linked awards. There are no commitments, obligations, agreements or other rights or arrangements existing which provide for the sale or issuance of capital stock by the Company and there are no rights, subscriptions, warrants, options, conversion rights or agreements of any kind outstanding to purchase or otherwise acquire from the Company any shares of capital stock or other securities of the Company of any kind, and there will not be any of the foregoing prior to or at the Closing. There are, and at the Closing there will be, no arrangements, commitments, agreements or other obligations (contingent or otherwise) which may require the Company to repurchase or otherwise acquire any shares of its capital stock.

(b) Schedule 4.4(b) contains a list, certified by the Company’s transfer agent and registrar, of the names of the owners of record as of the date of this Agreement of all issued and outstanding shares of Company Common Stock and the number of shares of Company Common Stock each of them holds.

(c) The Company does not have any Subsidiaries. The Company does not own, and is not party to any contract to acquire, any equity securities or other securities of any Person or any direct or indirect equity or ownership interest in any other Person. The Company is not a party to, and, to the Company’s Knowledge, there do not exist, any voting trusts, proxies, or other contracts with respect to the voting of shares of capital stock of the Company.

4.5 Validity of the Shares . The Shares, when issued, sold and delivered to Buyer pursuant to and in accordance with the terms and for the consideration set forth in this Agreement, will be duly authorized, validly issued, fully paid and nonassessable and free of preemptive rights and liens, claims or encumbrances or any kind whatsoever, other than restrictions on transfer under applicable state and federal securities laws. Assuming the accuracy of the representations of Buyer in Article III and subject to the filing of Form D with the SEC pursuant to Regulation D of the Securities Act and filings pursuant to applicable state securities laws, the Shares will be issued in compliance with all applicable federal and state securities laws.

4.6 Exchange Act Reports; Financial Statements.

(a) The Company has never filed a registration statement under the Exchange Act and has never registered any class of equity security under the Exchange Act. Since the filing of the Company’s Registration Statement on Form S-1 on May 2, 2012 (the “ Company Form S-1 ”), the Company has timely filed all reports, forms and documents that it was required to file with the SEC pursuant to the Exchange Act (such reports, forms and documents, together with the Company Form S-1 and any reports, forms and documents voluntarily filed by the Company with the SEC under the Exchange Act since the date of the Company Form S-1, the “ Company SEC Filings ”). As of their respective filing dates (or if amended or superseded by a subsequent filing prior to the date of this Agreement, on the date of such amending or

 

8


superseding filing), each of the Company SEC Filings (i) did not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading and (ii) complied as to form in all material respects with the Exchange Act and the applicable rules and regulations of the SEC promulgated thereunder.

(b) The Company has timely filed (or has been deemed to have timely filed pursuant to Rule 12b-25 under the Exchange Act) and made publicly available on the SEC’s EDGAR system, and Buyer may rely upon, all certifications and statements required by (i) Rule 13a-14 or Rule 15d-14 under the Exchange Act and (ii) Section 906 of the Sarbanes Oxley Act of 2002 with respect to any documents filed with the SEC. Since the most recent filing of such certifications and statements, there have been no significant changes in the Company’s internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act), or in other factors that could significantly affect its disclosure controls and procedures.

(c) The financial statements (including footnotes thereto) included in or incorporated by reference into the Company SEC Filings (the “ Company Financial Statements ”) were complete and correct in all material respects as of their respective filing dates, complied as to form in all material respects with the Exchange Act and the applicable accounting requirements, rules and regulations of the SEC promulgated thereunder as of their respective dates and have been prepared in accordance with GAAP applied on a consistent basis during the periods involved (except as otherwise noted therein). The Company Financial Statements fairly present the financial condition of the Company as of the dates thereof and the results of operations, cash flows and stockholders’ equity of the Company for the periods referred to therein (subject, in the case of unaudited Company Financial Statements, to normal recurring year-end adjustments). There has been no change in the Company’s accounting policies except as described in the notes to the Company Financial Statements.

4.7 Litigation . There are no actions, suits, proceedings, orders or investigations pending or, to the Knowledge of the Company, threatened against the Company or any of the Company’s officers, directors or employees, individually or in the aggregate, at law or in equity, or before or by any federal, state or other governmental department, court, commission, board, bureau, agency or instrumentality, domestic or foreign, and, to the Knowledge of the Company, there is no reasonable basis for any proceeding, claim, action or governmental investigation directly or indirectly involving the Company or any of the Company’s officers, directors or employees, individually or in the aggregate. The Company is not a party to any order, judgment or decree issued by any federal, state or other governmental department, court, commission, board, bureau, agency or instrumentality, domestic or foreign.

4.8 No Brokers or Finders . Except as set forth on Schedule 4.8 , none of the Company or any of its officers, directors, employees or Affiliates has employed any broker, finder, investment banker or investment advisor or Person performing a similar function, or incurred or will incur any liability for brokerage commissions, finders’ fees, investment advisory fees or similar compensation, in connection with the transactions contemplated by this Agreement.

4.9 Tax Matters.

 

9


(a)  (i) The Company has timely filed (or has had timely filed on its behalf) all returns, declarations, reports, estimates, information returns, and statements, including any schedules and amendments to such documents, required to be filed by it in respect of any Taxes (“ Returns ”); (ii) all such Returns are complete and accurate in all material respects; (iii) the Company has timely paid (or has had timely paid on its behalf) all Taxes required to have been paid by it (whether or not shown on any Return); (iv) the Company has established on the Company Latest Balance Sheet, in accordance with GAAP, reserves that are adequate for the payment of any Taxes not yet paid; and (v) the Company has complied with all applicable laws, rules and regulations relating to the collection or withholding of Taxes from third parties (including employees) and the payment thereof (including withholding of Taxes under Sections 1441 and 1442 of the Code, or similar provisions under any foreign laws).

(b) There are no liens for Taxes upon any assets of the Company, except statutory liens for current Taxes not yet due.

(c) No deficiency for any Taxes has been asserted, assessed or proposed against the Company that has not been finally resolved. No waiver, extension or comparable consent given by the Company regarding the application of the statute of limitations with respect to any Taxes or Returns is outstanding, nor is any request for any such waiver or consent pending. There is no pending or threatened Tax audit or other administrative proceeding or court proceeding with regard to any Taxes or Returns, nor is any such Tax audit or other proceeding pending, nor has there been any notice to the Company by any Taxing authority regarding any such Tax audit or other proceeding, or, to the Knowledge of the Company, is any such Tax audit or other proceeding threatened with regard to any Taxes or Returns. The Company does not expect the assessment of any additional Taxes of the Company for any period prior to the date hereof and has no Knowledge of any unresolved questions, claims or disputes concerning the liability for Taxes of the Company which would exceed the estimated reserves established on its books and records.

(d) Neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby, either alone or in combination with any other event (whether contingent or otherwise), will result in any “parachute payment” under Section 280G of the Code (or any corresponding provision of state, local, or foreign Tax law).

(e) There is no contract, agreement, plan or arrangement to which the Company is a party which requires the Company to pay a Tax gross-up, equalization or reimbursement payment to any Person, including with respect to any Tax-related payments under Section 409A of the Code or Section 280G of the Code.

(f) The Company is not liable for Taxes of any other Person under Treasury Regulations section 1.1502-6 or any similar provision of state, local or foreign Tax law, as a transferee or successor, by Contract or otherwise. The Company is not a party to any Tax sharing, allocation or indemnification agreement. The Company has not agreed, nor is the Company required, as a result of a change in method of accounting or otherwise, to include any adjustment under Section 481 of the Code (or any corresponding provision of state, local or foreign law) in Taxable income. The Company will not be required to include any item of income in Taxable income for any Taxable period (or portion thereof) ending after the Closing

 

10


Date as a result of any (i) prepaid amount received on or prior to the Closing Date or (ii) “closing agreement” described in Section 7121 of the Code (or any similar or corresponding provision of any other Tax law). No claim has ever been made by a Taxing authority in a jurisdiction where the Company does not file a Return that the Company is subject to Tax imposed by that jurisdiction. There are no advance rulings in respect of any Tax pending or issued by any Taxing authority with respect to any Taxes of the Company.

(g) The Company has not been a “distributing corporation” nor a “controlled corporation” (within the meaning of Section 355 of the Code) in a distribution of stock qualifying for tax-free treatment under Section 355 of the Code.

(h) The Company has not requested any extension of time within which to file any Return, which return has not since been filed.

4.10 Contracts and Commitments . Except as contemplated herein, the Company is not a party to any contract, agreement, arrangement or other understanding, whether written or oral, which is currently in effect, and which relates to the Company or its business.

4.11 Affiliate Transactions . No officer, director or employee of the Company, or any member of the immediate family of any such officer, director or employee, or any entity in which any of such persons owns any beneficial interest (other than any publicly-held corporation whose stock is traded on a national securities exchange or in an over-the-counter market and less than one percent (1%) of the stock of which is beneficially owned by any of such persons) (collectively “ Company Insiders ”), has any agreement with the Company or any interest in any property, real, personal or mixed, tangible or intangible, used in or pertaining to the business of the Company. The Company is not indebted to any Company Insider for any amounts and no Company Insider is indebted to the Company for any amounts. No Company Insider has any direct or indirect interest in any competitor, supplier or customer of the Company or in any Person from whom or to whom the Company leases any property, or in any other Person with whom the Company transacts business of any nature. For purposes of this Section 4.11, the members of the immediate family of an officer, director or employee shall consist of the spouse, parents, children or siblings of such officer, director or employee.

4.12 Compliance with Laws; Permits.

(a) The Company and its officers, directors, agents and employees have complied in all material respects with all applicable laws, regulations and other requirements, including federal, state, local and foreign laws, ordinances, rules, regulations and other requirements, including those pertaining to equal employment opportunity, employee retirement, affirmative action and other hiring practices, occupational safety and health, workers’ compensation, unemployment and building and zoning codes, and no claims have been filed against the Company or any of its officers, directors, agents or employees, and the Company has not received any notice, alleging a violation of any such laws, regulations or other requirements. The Company is not relying on any exemption from or deferral of any such applicable law, regulation or other requirement that would not be available to Buyer after it acquires the Company’s properties, assets and business.

 

11


(b) The Company has no licenses, permits or certificates from federal, state, local or foreign authorities (including federal and state agencies regulating occupational health and safety), and none are necessary or material to its operations and business.

4.13 Books and Records . The books of account, minute books, stock record books and other records of the Company, complete copies of which have been made available to Buyer, have been properly kept and contain no inaccuracies except for inaccuracies that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect on the Company. At the Closing, all of the Company’s records will be in the possession of the Company or its counsel.

4.14 Real Property. The Company does not own, lease or use any real property.

4.15 Insurance . The Company does not own or maintain any insurance policies.

4.16 No Undisclosed Liabilities . Except as reflected in the unaudited balance sheet of the Company as of June 30, 2013 included in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended on such date (the “ Company Latest Balance Sheet ”), the Company has no liabilities (whether accrued, absolute, contingent, unliquidated or otherwise) including any liabilities which have arisen after the date of the Company Latest Balance Sheet in the ordinary course of business or liabilities to its directors, officers and employees.

4.17 Environmental Matters . None of the operations of the Company involves the generation, transportation, treatment, storage or disposal of hazardous waste, as defined under 40 C.F.R. Parts 260-270, or any state, local or foreign equivalent.

4.18 Absence of Certain Developments . Except as disclosed in the Company SEC Filings or as otherwise contemplated by this Agreement, since the date of the Company Latest Balance Sheet, the Company has conducted its business only in the ordinary course consistent with past practice and there has not occurred or been entered into, as the case may be: (i) any event having a Material Adverse Effect on the Company, (ii) any event that would reasonably be expected to prevent or materially delay the performance of the Company’s obligations pursuant to this Agreement, (iii) any material change by the Company in its accounting methods, principles or practices, (iv) any declaration, setting aside or payment of any dividend or distribution in respect of the shares of capital stock of the Company or any redemption, purchase or other acquisition of any of the Company’s securities, other than the special dividend referred to in Section 6.2(g), (v) any increase in the compensation or benefits payable or to become payable to any officers or directors of the Company or establishment or modification of any Compensatory Plan, (vi) any issuance, grant or sale of any stock, options, warrants, notes, bonds or other securities, or entry into any agreement with respect thereto by the Company, (vii) any amendment to the certificate of incorporation or bylaws of the Company, other than the Company Charter Amendments, (viii) any (w) capital expenditures by the Company, (x) purchase, sale, assignment or transfer of any material assets by the Company, (y) mortgage, pledge or existence of any lien, encumbrance or charge on any material assets or properties, tangible or intangible, of the Company, except for liens for Taxes not yet due, or (z) cancellation, compromise, release or waiver by the Company of any rights of material value or any material debts or claims, (ix) any incurrence by the Company of any material liability (absolute or

 

12


contingent), except for current liabilities and obligations incurred in the ordinary course of business consistent with past practice (which liabilities are not material, individually or in the aggregate, and will have been paid, discharged and satisfied at or prior to the Closing), (x) damage, destruction or similar loss, whether or not covered by insurance, materially affecting the business or properties of the Company, (xi) entry by the Company into any agreement, contract, lease or license, other than the Original Term Sheet, Escrow Agreement No. 1, the Amended and Restated Term Sheet and Escrow Agreement No. 2, (xii) any acceleration, termination, modification or cancellation of any agreement, contract, lease or license to which the Company is a party or by which any of them is bound, (xiii) entry by the Company into any loan or other transaction with any officers, directors or employees of the Company, (xiv) any charitable or other capital contribution by the Company or pledge therefore, (xv) entry by the Company into any transaction of a material nature or (xvi) any negotiation or agreement by the Company to do any of the things described in the preceding clauses (i) through (xv).

4.19 Employee Benefit Plans.

(a) The Company does not sponsor, maintain or have any obligation or liability under, or has not at any time sponsored, maintained or had any obligation or liability under, any Compensatory Plan. Without limiting the generality of the foregoing, neither the Company nor any ERISA Affiliate sponsors, maintains or has any obligation or liability under, or has sponsored, maintained or had any obligation or liability under, any (i) “multiemployer plan” (within the meaning of Section 3(37) of ERISA), or (ii) single employer plan or other pension plan subject to Title IV or Section 302 of ERISA or Section 412 of the Code. The Company and its ERISA Affiliates are in compliance in all material respects with the applicable requirements of Section 4980B of the Code and any similar state law.

(b) Neither the execution of this Agreement nor the consummation of the transactions contemplated by this Agreement shall, individually or in the aggregate, (i) result in any payment becoming due to any officer, employee, consultant or director of the Company, (ii) increase or modify any benefits otherwise payable by the Company to any officer, employee, consultant or director of the Company or (iii) result in the acceleration of time of payment or vesting of any such benefits.

4.20 Employees . Except as disclosed in the Company SEC Filings, the Company does not have any employees and does not have any obligation or liability to any current or former officer, director, employee or Affiliate of the Company for wages, accrued vacation or otherwise. Each individual providing services to the Company has been properly classified as an employee or a non-employee service provider with respect to the Company for all purposes under applicable law. No current or former employee, consultant or director of the Company owes any indebtedness to the Company or any of its Affiliates. The Company is not, and has never been, a party to any collective bargaining or similar agreement, and there are no labor unions or other organizations representing, purporting to represent or, to the Knowledge of the Company, attempting to represent, any employee of the Company.

4.21 Proprietary Information and Inventions . No current employee of or consultant to the Company is party to either a non-disclosure and inventions assignment agreement or an

 

13


alternative employment agreement with the Company containing comparable non-disclosure and inventions assignment provisions.

4.22 Intellectual Property.

(a) The Company does not own or license the right to use any patents, copyrights, trademarks, know-how or software.

(b) The Company is not infringing upon the intellectual property or proprietary rights of any Person. There are no claims pending or, to the Company’s Knowledge, threatened alleging that the Company is currently infringing upon, using in an unauthorized manner or violating the intellectual property or proprietary rights of any Person.

(c) The Company is not, nor will it be as a result of the execution and delivery of this Agreement or the performance of its obligations hereunder, in breach of any license, sublicense or other agreement or contract relating to intellectual property or proprietary rights that would reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect on the Company.

4.23 Investment Company . The Company is not as of the date of this Agreement, nor upon the Closing will be, an “investment company,” a company controlled by an “investment company,” or an “affiliated person” of, or “promoter” or “principal underwriter” for, an “investment company,” as such terms are defined in the Investment Company Act of 1940, as amended.

4.24 Foreign Corrupt Practices . None of the Company or any director, officer or, to the knowledge of the Company, agent, employee or other Person acting on behalf of the Company, has, in the course of its actions for, or on behalf of, the Company: (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; (iii) violated or is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended; or (iv) made other unlawful payment to any foreign or domestic government official or employee.

4.25 No Integrated Offering . Neither the Company nor any Affiliates of the Company, nor any Person acting on the behalf of any of the foregoing, has, directly or indirectly, made any offers or sales of any security or solicited any offers to purchase any security, under circumstances that would require registration under the Securities Act of any of the Shares issuable to Buyer pursuant to this Agreement or cause such offering of Shares to be integrated with prior offerings by the Company for purposes of the Securities Act or any applicable shareholder approval requirements of any authority.

4.26 Application of Takeover Provisions . The Company and its Board of Directors have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, or other similar takeover, anti-takeover, moratorium, fair price, interested shareholder or similar provision under the certificate of incorporation of the Company or the laws of the State of Delaware with respect to the Company’s issuance and sale of the Shares to Buyer hereunder. The Company has never adopted any shareholder rights plan

 

14


or similar arrangement relating to accumulations of beneficial ownership of Company Common Stock or a change in control of the Company.

4.27 Information . All of the information provided by, or on behalf of, the Company regarding the Company or any of its officers, directors, employees, agents or other representatives, to Buyer or its representatives for purposes of, or otherwise in connection with, the preparation of any filings to be made with the SEC and any other governmental authority in connection with the consummation of the transactions contemplated hereby is accurate and complete in all material respects.

4.28 Full Disclosure . The representations and warranties of the Company contained in this Agreement (and in any schedule, exhibit, certificate or other instrument to be delivered under this Agreement) are true and correct in all material respects, and such representations and warranties do not omit any material fact necessary to make the statements contained therein, in light of the circumstances under which they were made, not misleading. There is no fact of which the Company has Knowledge that has not been disclosed to Buyer pursuant to this Agreement, including the schedules hereto, all taken together as a whole, which has had or would reasonably be expected to have a Material Adverse Effect on the Company or materially adversely affect the ability of the Company to consummate in a timely manner the transactions contemplated hereby.

ARTICLE V

ADDITIONAL COVENANTS AND AGREEMENTS

5.1 Further Assurances; Governmental Filings . At any time or from time to time after the Closing, each of the parties hereto shall, at the expense of the party making such request, execute and deliver such other documents and instruments, provide such materials and information and take such other actions as may reasonably be necessary, proper or advisable, to the extent permitted by law, to fulfill its obligations under this Agreement. Each party will use all reasonable efforts and will cooperate with the other party in the preparation and filing, as soon as practicable, of all filings, applications or other documents required under applicable laws, including the Exchange Act, to consummate, or otherwise in connection with, the transactions contemplated by this Agreement, including the filing with the SEC of a Form 8-K.

5.2 Expenses . Except as otherwise provided in this Agreement, all reasonable and documented costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such expenses. Without limiting the generality of the foregoing, any such costs and expenses incurred by the Company that remain unpaid as of the Closing, including any liability for brokerage commissions, finders’ fees, investment advisory fees or similar compensation in connection with the transactions contemplated by this Agreement, shall be paid by the Company using the proceeds from the sale of the Shares hereunder.

5.3 Private Placement . Each of Buyer and the Company shall take all necessary action on its part such that the issuance of the Shares to Buyer hereunder constitutes a valid “private placement” under the Securities Act.

 

15


ARTICLE VI

CONDITIONS

6.1 Conditions to Obligation of the Company . The obligation of the Company to issue and sell the Shares to Buyer at the Closing are subject to the fulfillment or waiver at or prior to the Closing of the following conditions:

(a) Representations and Compliance . The representations and warranties of Buyer contained in this Agreement shall be accurate as of the Closing in all respects (in the case of any representation or warranty containing any materiality qualification) and in all material respects (in the case of any representation or warranty not containing any materiality qualification), except for representations and warranties made as of a specific date, which shall be accurate as of such date. Buyer shall in all material respects have performed each obligation and agreement and complied with each covenant to be performed and complied with by it hereunder at or prior to the Closing.

(b) Officers’ Certificate . Buyer shall have furnished to the Company a certificate of the President of Buyer, dated as of the Closing Date, in which such officer certifies that, to the best of his Knowledge, the conditions set forth in Section 6.1(a) have been fulfilled.

(c) Secretary’s Certificate . Buyer shall have furnished to the Company (i) copies of the text of the resolutions by which the corporate action on the part of Buyer necessary to approve this Agreement and the transactions contemplated hereby were taken, (ii) a certificate dated as of the Closing Date executed on behalf of Buyer by its corporate secretary or one of its assistant corporate secretaries certifying to the Company (x) that such copies are true, correct and complete copies of such resolutions and that such resolutions were duly adopted and have not been amended or rescinded, and (y) the signature and office of each officer of Buyer executing this Agreement or any other agreement, certificate or other instrument executed pursuant hereto by Buyer, and (iii) a certificate from the Secretary of State of the State of Delaware evidencing the good standing of Buyer in such jurisdiction dated as of a recent date prior to the Closing Date.

(d) Consents and Approvals . Buyer shall have obtained all consents and approvals necessary to purchase the Shares pursuant to this Agreement, in order that Buyer’s purchase of the Shares hereunder not constitute a breach or violation of, or result in a right of termination or acceleration of, or the creation of any encumbrance on any of Buyer’s assets pursuant to the provisions of, any agreement, arrangement or undertaking of or affecting Buyer or any license, franchise or permit of or affecting Buyer.

6.2 Conditions to Obligation of Buyer . The obligation of Buyer to purchase the Shares at the Closing is subject to the fulfillment or waiver at or prior to the Closing of the following conditions:

(a) Representations and Compliance . The representations and warranties of the Company contained in this Agreement shall be accurate as of the Closing in all respects (in the case of any representation or warranty containing any materiality qualification) and in all material respects (in the case of any representation or warranty not containing any materiality

 

16


qualification), except for representations and warranties made as of a specific date, which shall be accurate as of such date. The Company shall in all material respects have performed each obligation and agreement and complied with each covenant to be performed and complied with by it hereunder at or prior to the Closing.

(b) Officers’ Certificate . The Company shall have furnished to Buyer a certificate of the President of the Company, dated as of the Closing Date, in which such officer certifies that, to the best of his Knowledge, the conditions set forth in Section 6.2(a) have been fulfilled.

(c) Secretary’s Certificate . The Company shall have furnished to Buyer (i) copies of the text of the resolutions by which the corporate action on the part of the Company necessary to approve this Agreement and the transactions contemplated hereby, and the election of the directors and officers of the Company to serve following the Closing Date (as set forth in Section 6.2(e)), were taken, (ii) a certificate dated as of the Closing Date executed on behalf the Company by its corporate secretary certifying to Buyer (x) that such copies are true, correct and complete copies of such resolutions and that such resolutions were duly adopted and have not been amended or rescinded, and (y) the signature and office of each officer of the Company executing this Agreement or any other agreement, certificate or other instrument executed pursuant hereto, (iii) a copy of the certificate of incorporation, as amended, of the Company, certified by the Secretary of State of the State of Delaware, and (iv) a certificate from the Secretary of State of the State of Delaware evidencing the good standing of the Company in such jurisdiction dated as of a recent date prior to the Closing Date.

(d) Consents and Approvals . The Company shall have obtained all consents and approvals necessary to consummate the transactions contemplated by this Agreement, in order that the transactions contemplated hereby not constitute a breach or violation of, or result in a right of termination or acceleration of, or the creation of any encumbrance on any of the Company’s assets pursuant to the provisions of, any agreement, arrangement or undertaking of or affecting the Company or any license, franchise or permit of or affecting the Company.

(e) Directors and Officers .

(i) The Board of Directors of the Company shall have taken the following actions, in compliance with applicable law, to be effective upon the Closing: (x) elected to the Board of Directors of the Company the persons who are the directors of Buyer, assigned to such classes as designated by Buyer; and (y) appointed as the officers of the Company those persons who are the officers of Buyer, or, in either case with regard to the foregoing clauses (x) and (y), such other persons designated by Buyer. Subject to applicable law, the Company shall have taken all action reasonably requested by Buyer, but consistent with the certificate of incorporation and bylaws of the Company, that is reasonably necessary to effect any such election or appointment of the designees of Buyer to the Company’s Board of Directors.

(ii) Each of the officers and directors of the Company immediately prior to the Closing shall have delivered duly executed resignations from their positions with the Company effective upon the Closing.

 

17


(iii) For the avoidance of doubt, the provisions of this Section 6.2(e) are in addition to and shall not limit any rights which Buyer may have as a holder or beneficial owner of shares of capital stock of the Company as a matter of law with respect to the election of directors or otherwise. The newly-appointed directors and officers of the Company shall hold office for the term specified in, and subject to the provisions contained in, the certificate of incorporation and bylaws of the Company and applicable law.

(f) Company Liabilities . The Company shall have no liabilities.

(g) Special Dividend . The Company shall have declared a cash dividend on the shares of Company Common Stock as of a record date prior to the Closing Date in an aggregate amount equal to the Purchase Price less the amount of all of the Company’s liabilities as of the Closing (it being acknowledged and agreed by the Company and Buyer that the payment of such dividend will occur as promptly as practicable following the Closing).

(h) Company Charter Amendments . The Company Charter Amendments shall continue to be in full force and effect as of the Closing.

(i) FIRPTA Certificate . The Company shall have delivered to Buyer a certificate, duly executed and acknowledged, in form and substance reasonably satisfactory to Buyer and in accordance with the provisions of Treasury Regulations Section 1.1445-2(b)(2), certifying that the transactions contemplated by this Agreement are exempt from withholding under Section 1445 of the Code.

ARTICLE VII

GENERAL PROVISIONS

7.1 Notices . All notices and other communications hereunder shall be in writing and shall be sufficiently given if made by hand delivery, by facsimile, by nationally recognized overnight delivery service for next business day delivery, or by registered or certified mail (return receipt requested), in each case with delivery charges prepaid, to the parties at the following addresses (or at such other address for a party as shall be specified by it by like notice):

 

  If to Buyer:   

ZP Holdings, Inc.

34790 Ardentech Court

Fremont, CA 94555

Facsimile: (510) 952-4632

Attn: President and CEO

  with a copy to:   

Foley Hoag LLP

155 Seaport Boulevard

Boston, MA 02210

Facsimile: (617) 832-7000

Attn: Jeffrey Quillen, Esq.

 

18


  If to the Company:   

Zosano, Inc.

93 South Jackson St., #34786

Seattle, WA 98104-2818

Facsimile: (866) 885-5653

E-mail: info@eco-p.org

Attn: Elka Yaron

  with a copy to:   

Szaferman Lakind Blumstein & Blader, PC

101 Grovers Mill Road, Second Floor

Lawrenceville, NJ 08648

Facsimile: (609) 557-0969

E-mail: gjaclin@szaferman.com

Attn: Gregg Jaclin, Esq.

All such notices and other communications shall be deemed to have been duly given as follows: (i) if delivered by hand, when received; (ii) if delivered by registered or certified mail (return receipt requested), when receipt acknowledged; or (iii) if via facsimile, on the day of transmission or, if that day is not a business day, on the next business day; and (iv) if delivered by a recognized overnight delivery service, on the next business day delivery after being timely delivered by the sender to such recognized overnight delivery service.

7.2 No Survival . None of the representations, warranties, covenants and other agreements in this Agreement or in any instrument delivered pursuant to this Agreement, including any rights arising out of any breach of any such representations, warranties, covenants or other agreements, shall survive the Closing, except for this Article VII and those covenants and agreements herein that by their terms apply or are to be performed in whole or in part after the Closing.

7.3 Interpretation . The headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. References to Sections and Articles refer to Sections and Articles of this Agreement unless otherwise stated. Words such as “herein,” “hereinafter,” “hereof,” “hereto,” “hereby” and “hereunder,” and words of like import, unless the context requires otherwise, refer to this Agreement (including the Schedules hereto). Unless the context otherwise requires, the words “include,” “includes” and “including” are deemed to be followed by “without limitation” whether or not they are followed by such words or words of similar impart. As used in this Agreement, the masculine, feminine and neuter genders shall be deemed to include the others if the context requires.

7.4 Severability . If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Agreement shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties shall negotiate in good faith to modify this Agreement and to preserve each party’s anticipated benefits under this Agreement.

 

19


7.5 Amendment . This Agreement may not be amended or modified except by an instrument in writing approved by the parties to this Agreement and signed on behalf of each of the parties hereto.

7.6 Waiver . Any party hereto may (a) extend the time for the performance of any of the obligations or other acts of the other party hereto or (b) waive compliance with any of the agreements of the other party or with any conditions to its own obligations, in each case only to the extent such obligations, agreements and conditions are intended for its benefit. Any such extension or waiver shall only be effective if made in writing and duly executed by the party giving such extension or waiver.

7.7 Miscellaneous . This Agreement (together with all other documents and instruments referred to herein, including Escrow Agreement No. 1 and Escrow Agreement No. 2): (a) constitutes the entire agreement, and supersedes all other prior agreements and undertakings, both written and oral, among the parties with respect to the subject matter hereof; and (b) shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns, but shall not be assignable by any party hereto without the prior written consent of the other parties hereto.

7.8 Counterparts; Facsimile Signatures . This Agreement may be executed in two or more counterparts, all of which together shall constitute a single agreement. This Agreement and any documents relating to it may be executed and transmitted to any other party by facsimile or email of a PDF, which facsimile or PDF shall be deemed to be, and utilized in all respects as, an original, wet-inked document.

7.9 Third Party Beneficiaries . Each party hereto intends that this Agreement, except as expressly provided herein, shall not benefit or create any right or cause of action in or on behalf of any person other than the parties hereto.

7.10 Governing Law . This Agreement is governed by the internal laws of the State of Delaware without regard to such State’s principles of conflicts of laws that would defer to the substantive laws of another jurisdiction.

7.11 Jurisdiction; Service of Process . Any action or proceeding seeking to enforce any provision of, or based on any right arising out of, this Agreement must, to the extent such courts will accept such jurisdiction, be brought against any of the parties in the courts of the State of Delaware, or, if it has or can acquire jurisdiction, in the United States District Court for the District of Delaware, and each of the parties consents to the jurisdiction of those courts (and of the appropriate appellate courts) in any such action or proceeding and waives any objection to venue laid therein. Process in any such action or proceeding may be served by sending or delivering a copy of the process to the party to be served at the address and in the manner provided for the giving of notices in Section 7.1. Nothing in this Section 7.11, however, affects the right of any party to serve legal process in any other manner permitted by law.

7.12 Waiver of Jury Trial . Each party hereby waives its rights to a jury trial of any claim or cause of action based upon or arising out of this Agreement, the Shares or the subject matter hereof. The scope of this waiver is intended to be all-encompassing of any and all

 

20


disputes that may be filed in any court and that relate to the subject matter of this transaction, including contract claims, tort claims, breach of duty claims, and all other common law and statutory claims. Each party hereto hereby represents and warrants that such party has reviewed this waiver with its legal counsel, and that such party knowingly and voluntarily waives its jury trial rights following consultation with legal counsel.

7.13 Disclosure in Schedules . For purposes of this Agreement, with respect to any matter that is clearly disclosed on any Schedule hereto with respect to any Section hereof in such a way as to make its relevance to the information called for by another Section hereof or any other Schedule, as the case may be, reasonably apparent, such matter shall be deemed to have been disclosed in response to such other Section or Schedule, notwithstanding the omission of any appropriate cross-reference thereto; provided, however , that each of the Company and Buyer hereby covenants to make a good faith diligent effort to make all appropriate cross-references within and to any and all Sections of this Agreement and Schedules hereto.

[ Remainder of Page Left Intentionally Blank ]

 

21


IN WITNESS WHEREOF , the parties hereto have caused this Agreement to be executed on the date first written above by their respective officers.

 

ZP HOLDINGS, INC.
By:   /s/ Vikram Lamba
 

Name: Vikram Lamba

Title: President and Chief Executive Officer

 

ZOSANO, INC.
By:   /s/ Elka Yaron
 

Name: Elka Yaron

Title: President and Chief Executive Officer

Signature Page to Stock Purchase Agreement